Please login to the form below

Not currently logged in
Email:
Password:

Sally Waterman appointed as chair of OBN

She succeeds David Laskow-Pooley

OBN Sally WatermanOBN has appointed Sally Waterman as its new chair, succeeding David Laskow-Pooley with immediate effect.

Waterman has been a member of OBN's board of directors since January 2014 when she joined as a non-executive director. She has over 25 years of experience in the life sciences industry and currently serves as senior vice president of corporate development at Abzena, a biopharmaceuticals company.

Prior to this, Waterman has held several operational and research and development positions including chief operating officer for PolyTherics, director of research and development at Protherics and director of development operations at Xenova.

Laskow-Pooley said: “I am delighted that Sally will be succeeding me as chair. Her extensive experience of the life sciences sector, her significant board experience and her personal qualities will be invaluable to OBN.”

Laskow-Pooley stepped down as chair after eight years in the role and will continue on at OBN as a non-executive director.

Waterman added: “On behalf of OBN and the board I would like to thank David for the enormous contribution he has made to the development and success of OBN and wish him well with his future plans, both in the UK and USA.”

16th March 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health

Cello Health’s mission is to help our clients unlock the potential that exists with their assets, brands and organisations in...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics